QUEST DIAGNOSTICS INC
DGX
Transaktioner
1000
Köp
485
Sälj
515
Nettoinsynsflöde
-92.7 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
1000 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 23 k | 112,17 | 2.5 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 16 k | 242,88 | 3.9 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 243,63 | 1.5 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 430 | 244,51 | 105 k USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 0,00 | 0 USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 23 k | 112,17 | 2.5 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 16 k | 242,88 | 3.9 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 243,63 | 1.5 mn USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 430 | 244,51 | 105 k USD |
| 2026-08-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 0,00 | 0 USD |
| 2026-07-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 235,18 | 376 k USD |
| 2026-07-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 235,18 | 376 k USD |
| 2026-07-22 | CARTER ROBERT B | Director | Buy | 11 | 206,80 | 2 k USD |
| 2026-07-22 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 34 | 206,81 | 7 k USD |
| 2026-07-22 | Gregg Vicky B | Director | Buy | 72 | 206,81 | 15 k USD |
| 2026-07-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 37 | 206,81 | 8 k USD |
| 2026-07-22 | Lassiter Wright III | Director | Buy | 6 | 206,81 | 1 k USD |
| 2026-07-22 | MAIN TIMOTHY L | Director | Buy | 21 | 206,81 | 4 k USD |
| 2026-07-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 46 | 206,81 | 10 k USD |
| 2026-07-22 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 34 | 206,81 | 7 k USD |
| 2026-07-22 | Lassiter Wright III | Director | Buy | 6 | 206,81 | 1 k USD |
| 2026-07-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 102 | 206,81 | 21 k USD |
| 2026-07-22 | MAIN TIMOTHY L | Director | Buy | 21 | 206,81 | 4 k USD |
| 2026-07-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 46 | 206,81 | 10 k USD |
| 2026-07-22 | Gregg Vicky B | Director | Buy | 72 | 206,81 | 15 k USD |
| 2026-07-22 | CARTER ROBERT B | Director | Buy | 11 | 206,80 | 2 k USD |
| 2026-07-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 37 | 206,81 | 8 k USD |
| 2026-07-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 102 | 206,81 | 21 k USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 127,73 | 424 k USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 5 k | 121,81 | 588 k USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 8 k | 200,00 | 1.6 mn USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 127,73 | 424 k USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 5 k | 121,81 | 588 k USD |
| 2026-06-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 8 k | 200,00 | 1.6 mn USD |
| 2026-06-01 | Davis J. E. | CEO and President | Sell | 10 k | 194,14 | 1.9 mn USD |
| 2026-06-01 | Davis J. E. | CEO and President | Sell | 10 k | 194,14 | 1.9 mn USD |
| 2026-05-20 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | WENTWORTH TIMOTHY C | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-05-20 | WENTWORTH TIMOTHY C | Director | Buy | 1 k | 0,00 | 0 USD |
| 2026-04-20 | CARTER ROBERT B | Director | Buy | 7 | 194,70 | 1 k USD |
| 2026-04-20 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 37 | 194,70 | 7 k USD |
| 2026-04-20 | Gregg Vicky B | Director | Buy | 68 | 194,70 | 13 k USD |
| 2026-04-20 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 39 | 194,70 | 8 k USD |
| 2026-04-20 | Lassiter Wright III | Director | Buy | 6 | 194,70 | 1 k USD |
| 2026-04-20 | Plewman Patrick | SVP for Diagnostic Services | Buy | 49 | 194,70 | 10 k USD |
| 2026-04-20 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 37 | 194,70 | 7 k USD |
| 2026-04-20 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 39 | 194,70 | 8 k USD |
| 2026-04-20 | Lassiter Wright III | Director | Buy | 6 | 194,70 | 1 k USD |
| 2026-04-20 | CARTER ROBERT B | Director | Buy | 7 | 194,70 | 1 k USD |
| 2026-04-20 | Gregg Vicky B | Director | Buy | 68 | 194,70 | 13 k USD |
| 2026-04-20 | Plewman Patrick | SVP for Diagnostic Services | Buy | 49 | 194,70 | 10 k USD |
| 2026-04-20 | SAMAD SAM | Executive Vice President & CFO | Buy | 108 | 194,70 | 21 k USD |
| 2026-04-20 | SAMAD SAM | Executive Vice President & CFO | Buy | 108 | 194,70 | 21 k USD |
| 2026-03-09 | WENTWORTH TIMOTHY C | Director | Buy | 215 | 0,00 | 0 USD |
| 2026-03-09 | WENTWORTH TIMOTHY C | Director | Buy | 215 | 0,00 | 0 USD |
| 2026-03-05 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 206,21 | 1.1 mn USD |
| 2026-03-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 206,21 | 800 k USD |
| 2026-03-05 | Plewman Patrick | SVP for Diagnostic Services | Sell | 3 k | 206,21 | 589 k USD |
| 2026-03-05 | Plewman Patrick | SVP for Diagnostic Services | Sell | 3 k | 206,21 | 589 k USD |
| 2026-03-05 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 206,21 | 800 k USD |
| 2026-03-05 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 206,21 | 1.1 mn USD |
| 2026-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 204,86 | 477 k USD |
| 2026-03-04 | Davis J. E. | CEO and President | Buy | 52 k | 204,86 | 10.6 mn USD |
| 2026-03-04 | Davis J. E. | CEO and President | Sell | 26 k | 204,86 | 5.4 mn USD |
| 2026-03-04 | Deppe Michael J | SVP, Corp. Controller & CAO | Buy | 1 k | 204,86 | 302 k USD |
| 2026-03-04 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 750 | 204,86 | 154 k USD |
| 2026-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 11 k | 204,86 | 2.3 mn USD |
| 2026-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 6 k | 204,86 | 1.3 mn USD |
| 2026-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 204,86 | 538 k USD |
| 2026-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 7 k | 204,86 | 1.5 mn USD |
| 2026-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 204,86 | 687 k USD |
| 2026-03-04 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | Plewman Patrick | SVP for Diagnostic Services | Sell | 3 k | 204,86 | 579 k USD |
| 2026-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 6 k | 204,86 | 1.3 mn USD |
| 2026-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 204,86 | 538 k USD |
| 2026-03-04 | Deppe Michael J | SVP, Corp. Controller & CAO | Buy | 1 k | 204,86 | 302 k USD |
| 2026-03-04 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 750 | 204,86 | 154 k USD |
| 2026-03-04 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | Plewman Patrick | SVP for Diagnostic Services | Sell | 3 k | 204,86 | 579 k USD |
| 2026-03-04 | Davis J. E. | CEO and President | Buy | 52 k | 204,86 | 10.6 mn USD |
| 2026-03-04 | Davis J. E. | CEO and President | Sell | 26 k | 204,86 | 5.4 mn USD |
| 2026-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 7 k | 204,86 | 1.5 mn USD |
| 2026-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 204,86 | 687 k USD |
| 2026-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 204,86 | 477 k USD |
| 2026-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 11 k | 204,86 | 2.3 mn USD |
| 2026-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 204,86 | 1.2 mn USD |
| 2026-03-04 | SAMAD SAM | Executive Vice President & CFO | Buy | 14 k | 204,86 | 2.9 mn USD |
| 2026-03-04 | SAMAD SAM | Executive Vice President & CFO | Sell | 8 k | 204,86 | 1.6 mn USD |
| 2026-03-04 | SAMAD SAM | Executive Vice President & CFO | Buy | 14 k | 204,86 | 2.9 mn USD |
| 2026-03-04 | SAMAD SAM | Executive Vice President & CFO | Sell | 8 k | 204,86 | 1.6 mn USD |
| 2026-03-03 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 632 | 207,73 | 131 k USD |
| 2026-03-03 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 526 | 207,73 | 109 k USD |
| 2026-03-03 | Plewman Patrick | SVP for Diagnostic Services | Sell | 410 | 207,73 | 85 k USD |
| 2026-03-03 | Plewman Patrick | SVP for Diagnostic Services | Sell | 410 | 207,73 | 85 k USD |
| 2026-03-03 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 526 | 207,73 | 109 k USD |
| 2026-03-03 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 632 | 207,73 | 131 k USD |
| 2026-03-02 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 188 | 204,86 | 39 k USD |
| 2026-03-02 | Davis J. E. | CEO and President | Sell | 3 k | 204,86 | 608 k USD |
| 2026-03-02 | Davis J. E. | CEO and President | Sell | 10 k | 212,52 | 2.1 mn USD |
| 2026-03-02 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 88 | 204,86 | 18 k USD |
| 2026-03-02 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 648 | 204,86 | 133 k USD |
| 2026-03-02 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 205 | 204,86 | 42 k USD |
| 2026-03-02 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 288 | 204,86 | 59 k USD |
| 2026-03-02 | Plewman Patrick | SVP for Diagnostic Services | Sell | 230 | 204,86 | 47 k USD |
| 2026-03-02 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 88 | 204,86 | 18 k USD |
| 2026-03-02 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 188 | 204,86 | 39 k USD |
| 2026-03-02 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 205 | 204,86 | 42 k USD |
| 2026-03-02 | Plewman Patrick | SVP for Diagnostic Services | Sell | 230 | 204,86 | 47 k USD |
| 2026-03-02 | Davis J. E. | CEO and President | Sell | 3 k | 204,86 | 608 k USD |
| 2026-03-02 | Davis J. E. | CEO and President | Sell | 10 k | 212,52 | 2.1 mn USD |
| 2026-03-02 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 288 | 204,86 | 59 k USD |
| 2026-03-02 | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | 204,86 | 178 k USD |
| 2026-03-02 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 648 | 204,86 | 133 k USD |
| 2026-03-02 | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | 204,86 | 178 k USD |
| 2026-02-19 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1 k | 204,83 | 294 k USD |
| 2026-02-19 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 204,83 | 228 k USD |
| 2026-02-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 958 | 204,83 | 196 k USD |
| 2026-02-19 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 204,83 | 228 k USD |
| 2026-02-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 958 | 204,83 | 196 k USD |
| 2026-02-19 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1 k | 204,83 | 294 k USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 205 | 210,01 | 43 k USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 230 | 206,99 | 48 k USD |
| 2026-02-18 | Davis J. E. | CEO and President | Buy | 16 k | 0,00 | 0 USD |
| 2026-02-18 | Davis J. E. | CEO and President | Sell | 2 k | 210,01 | 503 k USD |
| 2026-02-18 | Davis J. E. | CEO and President | Sell | 4 k | 206,99 | 784 k USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Buy | 366 | 0,00 | 0 USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 83 | 210,01 | 17 k USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 99 | 206,99 | 20 k USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 433 | 210,01 | 91 k USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 728 | 206,99 | 151 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 252 | 210,01 | 53 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 259 | 206,99 | 54 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 301 | 210,01 | 63 k USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 347 | 206,99 | 72 k USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Sell | 244 | 210,01 | 51 k USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Sell | 293 | 206,99 | 61 k USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 301 | 210,01 | 63 k USD |
| 2026-02-18 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 347 | 206,99 | 72 k USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Sell | 244 | 210,01 | 51 k USD |
| 2026-02-18 | Plewman Patrick | SVP for Diagnostic Services | Sell | 293 | 206,99 | 61 k USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 433 | 210,01 | 91 k USD |
| 2026-02-18 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 728 | 206,99 | 151 k USD |
| 2026-02-18 | Davis J. E. | CEO and President | Buy | 16 k | 0,00 | 0 USD |
| 2026-02-18 | Davis J. E. | CEO and President | Sell | 2 k | 210,01 | 503 k USD |
| 2026-02-18 | Davis J. E. | CEO and President | Sell | 4 k | 206,99 | 784 k USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Buy | 4 k | 0,00 | 0 USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Sell | 855 | 210,01 | 180 k USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Sell | 1 k | 206,99 | 209 k USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Buy | 366 | 0,00 | 0 USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 83 | 210,01 | 17 k USD |
| 2026-02-18 | Deppe Michael J | SVP, Corp. Controller & CAO | Sell | 99 | 206,99 | 20 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 252 | 210,01 | 53 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 259 | 206,99 | 54 k USD |
| 2026-02-18 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 205 | 210,01 | 43 k USD |
| 2026-02-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 230 | 206,99 | 48 k USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Buy | 4 k | 0,00 | 0 USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Sell | 855 | 210,01 | 180 k USD |
| 2026-02-18 | SAMAD SAM | Executive Vice President & CFO | Sell | 1 k | 206,99 | 209 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 26 k | 112,17 | 2.9 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 11 k | 205,21 | 2.2 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 10 k | 206,37 | 2.1 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 4 k | 207,08 | 725 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 2 k | 208,21 | 337 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 351 | 209,10 | 73 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 26 k | 112,17 | 2.9 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 11 k | 205,21 | 2.2 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 10 k | 206,37 | 2.1 mn USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 4 k | 207,08 | 725 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 2 k | 208,21 | 337 k USD |
| 2026-02-13 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 351 | 209,10 | 73 k USD |
| 2026-02-10 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 121,81 | 690 k USD |
| 2026-02-10 | Plewman Patrick | SVP for Diagnostic Services | Sell | 6 k | 204,00 | 1.2 mn USD |
| 2026-02-10 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 121,81 | 690 k USD |
| 2026-02-10 | Plewman Patrick | SVP for Diagnostic Services | Sell | 6 k | 204,00 | 1.2 mn USD |
| 2026-01-28 | CARTER ROBERT B | Director | Buy | 6 | 183,51 | 1 k USD |
| 2026-01-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 15 | 183,51 | 3 k USD |
| 2026-01-28 | Gregg Vicky B | Director | Buy | 67 | 183,51 | 12 k USD |
| 2026-01-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 16 | 183,52 | 3 k USD |
| 2026-01-28 | Lassiter Wright III | Director | Buy | 7 | 183,51 | 1 k USD |
| 2026-01-28 | Lassiter Wright III | Director | Buy | 7 | 183,51 | 1 k USD |
| 2026-01-28 | CARTER ROBERT B | Director | Buy | 6 | 183,51 | 1 k USD |
| 2026-01-28 | Gregg Vicky B | Director | Buy | 67 | 183,51 | 12 k USD |
| 2026-01-28 | SAMAD SAM | Executive Vice President & CFO | Buy | 69 | 183,51 | 13 k USD |
| 2026-01-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 16 | 183,52 | 3 k USD |
| 2026-01-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 15 | 183,51 | 3 k USD |
| 2026-01-28 | SAMAD SAM | Executive Vice President & CFO | Buy | 69 | 183,51 | 13 k USD |
| 2026-01-28 | Plewman Patrick | SVP for Diagnostic Services | Buy | 48 | 183,51 | 9 k USD |
| 2026-01-28 | Plewman Patrick | SVP for Diagnostic Services | Buy | 48 | 183,51 | 9 k USD |
| 2025-11-25 | Davis J. E. | CEO and President | Buy | 55 k | 95,80 | 5.3 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 9 k | 191,59 | 1.8 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 41 k | 192,27 | 7.9 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 5 k | 192,97 | 916 k USD |
| 2025-11-25 | Gregg Vicky B | Director | Sell | 1 k | 191,76 | 240 k USD |
| 2025-11-25 | Gregg Vicky B | Director | Sell | 1 k | 191,76 | 240 k USD |
| 2025-11-25 | Davis J. E. | CEO and President | Buy | 55 k | 95,80 | 5.3 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 9 k | 191,59 | 1.8 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 41 k | 192,27 | 7.9 mn USD |
| 2025-11-25 | Davis J. E. | CEO and President | Sell | 5 k | 192,97 | 916 k USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 8 k | 144,47 | 1.1 mn USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 100 | 143,33 | 14 k USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 8 k | 187,35 | 1.5 mn USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 8 k | 144,47 | 1.1 mn USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 100 | 143,33 | 14 k USD |
| 2025-11-18 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 8 k | 187,35 | 1.5 mn USD |
| 2025-11-05 | Davis J. E. | CEO and President | Sell | 7 k | 175,57 | 1.3 mn USD |
| 2025-11-05 | Davis J. E. | CEO and President | Sell | 7 k | 175,57 | 1.3 mn USD |
| 2025-10-22 | PFEIFFER GARY M | Director | Sell | 1 k | 182,40 | 270 k USD |
| 2025-10-22 | PFEIFFER GARY M | Director | Sell | 1 k | 182,40 | 270 k USD |
| 2025-10-21 | CARTER ROBERT B | Director | Buy | 6 | 189,09 | 1 k USD |
| 2025-10-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 15 | 189,08 | 3 k USD |
| 2025-10-21 | Gregg Vicky B | Director | Buy | 70 | 189,08 | 13 k USD |
| 2025-10-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 15 | 189,08 | 3 k USD |
| 2025-10-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 46 | 189,08 | 9 k USD |
| 2025-10-21 | CARTER ROBERT B | Director | Buy | 6 | 189,09 | 1 k USD |
| 2025-10-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 15 | 189,08 | 3 k USD |
| 2025-10-21 | Gregg Vicky B | Director | Buy | 70 | 189,08 | 13 k USD |
| 2025-10-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 15 | 189,08 | 3 k USD |
| 2025-10-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 46 | 189,08 | 9 k USD |
| 2025-10-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 68 | 189,08 | 13 k USD |
| 2025-10-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 68 | 189,08 | 13 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 227 | 103,57 | 24 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 83 | 187,22 | 16 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 144 | 188,66 | 27 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 227 | 103,57 | 24 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 83 | 187,22 | 16 k USD |
| 2025-09-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 144 | 188,66 | 27 k USD |
| 2025-09-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 175 | 103,57 | 18 k USD |
| 2025-09-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 175 | 187,02 | 33 k USD |
| 2025-09-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 175 | 103,57 | 18 k USD |
| 2025-09-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 175 | 187,02 | 33 k USD |
| 2025-09-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 28 k | 103,57 | 2.9 mn USD |
| 2025-09-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 28 k | 187,12 | 5.3 mn USD |
| 2025-09-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 28 k | 103,57 | 2.9 mn USD |
| 2025-09-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 28 k | 187,12 | 5.3 mn USD |
| 2025-08-21 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 185,00 | 365 k USD |
| 2025-08-21 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 185,00 | 365 k USD |
| 2025-08-19 | Plewman Patrick | SVP for Diagnostic Services | Buy | 5 k | 112,17 | 508 k USD |
| 2025-08-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 5 k | 183,00 | 829 k USD |
| 2025-08-19 | Plewman Patrick | SVP for Diagnostic Services | Buy | 5 k | 112,17 | 508 k USD |
| 2025-08-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 5 k | 183,00 | 829 k USD |
| 2025-08-15 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 180,00 | 356 k USD |
| 2025-08-15 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 180,00 | 356 k USD |
| 2025-08-13 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 123 | 175,91 | 22 k USD |
| 2025-08-13 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 123 | 175,91 | 22 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Buy | 4 k | 86,63 | 308 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 4 k | 175,00 | 623 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 175,00 | 346 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Buy | 4 k | 86,63 | 308 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 4 k | 175,00 | 623 k USD |
| 2025-08-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 175,00 | 346 k USD |
| 2025-07-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 170,00 | 376 k USD |
| 2025-07-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 170,00 | 376 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 86,63 | 264 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 167,40 | 510 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 5 k | 112,17 | 586 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 5 k | 167,40 | 874 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 86,63 | 264 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 167,40 | 510 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 5 k | 112,17 | 586 k USD |
| 2025-07-30 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 5 k | 167,40 | 874 k USD |
| 2025-07-21 | CARTER ROBERT B | Director | Buy | 7 | 167,51 | 1 k USD |
| 2025-07-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 17 | 167,49 | 3 k USD |
| 2025-07-21 | Gregg Vicky B | Director | Buy | 79 | 167,50 | 13 k USD |
| 2025-07-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 27 | 167,50 | 5 k USD |
| 2025-07-21 | Lassiter Wright III | Director | Buy | 7 | 167,51 | 1 k USD |
| 2025-07-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 80 | 167,49 | 13 k USD |
| 2025-07-21 | CARTER ROBERT B | Director | Buy | 7 | 167,51 | 1 k USD |
| 2025-07-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 17 | 167,49 | 3 k USD |
| 2025-07-21 | Gregg Vicky B | Director | Buy | 79 | 167,50 | 13 k USD |
| 2025-07-21 | Lassiter Wright III | Director | Buy | 7 | 167,51 | 1 k USD |
| 2025-07-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 27 | 167,50 | 5 k USD |
| 2025-07-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 80 | 167,49 | 13 k USD |
| 2025-07-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 72 | 167,50 | 12 k USD |
| 2025-07-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 72 | 167,50 | 12 k USD |
| 2025-07-16 | SAMAD SAM | Executive Vice President & CFO | Sell | 850 | 169,01 | 144 k USD |
| 2025-07-16 | SAMAD SAM | Executive Vice President & CFO | Sell | 850 | 169,01 | 144 k USD |
| 2025-05-15 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-15 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2025-05-13 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 874 | 175,31 | 153 k USD |
| 2025-05-13 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 874 | 175,31 | 153 k USD |
| 2025-05-12 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 874 | 175,72 | 154 k USD |
| 2025-05-12 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 874 | 175,72 | 154 k USD |
| 2025-04-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 25 | 164,42 | 4 k USD |
| 2025-04-21 | Gregg Vicky B | Director | Buy | 68 | 164,42 | 11 k USD |
| 2025-04-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 27 | 164,42 | 4 k USD |
| 2025-04-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 81 | 164,42 | 13 k USD |
| 2025-04-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 25 | 164,42 | 4 k USD |
| 2025-04-21 | Gregg Vicky B | Director | Buy | 68 | 164,42 | 11 k USD |
| 2025-04-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 81 | 164,42 | 13 k USD |
| 2025-04-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 27 | 164,42 | 4 k USD |
| 2025-04-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 74 | 164,42 | 12 k USD |
| 2025-04-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 74 | 164,42 | 12 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 2 k | 168,03 | 398 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 1 k | 168,76 | 238 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 704 | 169,63 | 119 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 7 k | 167,86 | 1.2 mn USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 5 k | 168,72 | 828 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 3 k | 169,56 | 469 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 7 k | 167,86 | 1.2 mn USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 6 k | 168,66 | 995 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 2 k | 169,57 | 423 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 750 | 167,86 | 126 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 584 | 168,70 | 99 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 267 | 169,60 | 45 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 1 k | 167,88 | 251 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 902 | 168,79 | 152 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 453 | 169,63 | 77 k USD |
| 2025-04-02 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 170,00 | 434 k USD |
| 2025-04-02 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 3 k | 170,00 | 434 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 2 k | 168,03 | 398 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 1 k | 168,76 | 238 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 704 | 169,63 | 119 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 7 k | 167,86 | 1.2 mn USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 5 k | 168,72 | 828 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 3 k | 169,56 | 469 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 7 k | 167,86 | 1.2 mn USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 6 k | 168,66 | 995 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 2 k | 169,57 | 423 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 750 | 167,86 | 126 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 584 | 168,70 | 99 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 267 | 169,60 | 45 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 1 k | 167,88 | 251 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 902 | 168,79 | 152 k USD |
| 2025-04-02 | Davis J. E. | CEO and President | Sell | 453 | 169,63 | 77 k USD |
| 2025-03-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 256 | 166,71 | 43 k USD |
| 2025-03-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 162 | 166,71 | 27 k USD |
| 2025-03-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 256 | 166,71 | 43 k USD |
| 2025-03-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 162 | 166,71 | 27 k USD |
| 2025-03-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 170,00 | 789 k USD |
| 2025-03-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 170,00 | 789 k USD |
| 2025-03-05 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 174,13 | 935 k USD |
| 2025-03-05 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 174,13 | 935 k USD |
| 2025-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 5 k | 173,74 | 924 k USD |
| 2025-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 173,74 | 317 k USD |
| 2025-03-04 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 2 k | 173,74 | 297 k USD |
| 2025-03-04 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 867 | 173,74 | 151 k USD |
| 2025-03-04 | Davis J. E. | CEO and President | Buy | 62 k | 173,74 | 10.8 mn USD |
| 2025-03-04 | Davis J. E. | CEO and President | Sell | 32 k | 173,74 | 5.5 mn USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 716 | 175,79 | 126 k USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 10 k | 173,74 | 1.8 mn USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 173,74 | 870 k USD |
| 2025-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 4 k | 173,74 | 770 k USD |
| 2025-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 173,74 | 326 k USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 592 | 175,79 | 104 k USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 9 k | 173,74 | 1.5 mn USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 173,74 | 679 k USD |
| 2025-03-04 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 173,74 | 986 k USD |
| 2025-03-04 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 173,74 | 396 k USD |
| 2025-03-04 | SAMAD SAM | Executive Vice President & CFO | Buy | 14 k | 173,74 | 2.4 mn USD |
| 2025-03-04 | SAMAD SAM | Executive Vice President & CFO | Sell | 8 k | 173,74 | 1.3 mn USD |
| 2025-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 5 k | 173,74 | 924 k USD |
| 2025-03-04 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 2 k | 173,74 | 317 k USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 592 | 175,79 | 104 k USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 9 k | 173,74 | 1.5 mn USD |
| 2025-03-04 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 173,74 | 679 k USD |
| 2025-03-04 | Plewman Patrick | SVP for Diagnostic Services | Buy | 6 k | 173,74 | 986 k USD |
| 2025-03-04 | Plewman Patrick | SVP for Diagnostic Services | Sell | 2 k | 173,74 | 396 k USD |
| 2025-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 4 k | 173,74 | 770 k USD |
| 2025-03-04 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 173,74 | 326 k USD |
| 2025-03-04 | Davis J. E. | CEO and President | Buy | 62 k | 173,74 | 10.8 mn USD |
| 2025-03-04 | Davis J. E. | CEO and President | Sell | 32 k | 173,74 | 5.5 mn USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 716 | 175,79 | 126 k USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 10 k | 173,74 | 1.8 mn USD |
| 2025-03-04 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 173,74 | 870 k USD |
| 2025-03-04 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 2 k | 173,74 | 297 k USD |
| 2025-03-04 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 867 | 173,74 | 151 k USD |
| 2025-03-04 | SAMAD SAM | Executive Vice President & CFO | Buy | 14 k | 173,74 | 2.4 mn USD |
| 2025-03-04 | SAMAD SAM | Executive Vice President & CFO | Sell | 8 k | 173,74 | 1.3 mn USD |
| 2025-03-03 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 173,74 | 294 k USD |
| 2025-03-03 | Davis J. E. | CEO and President | Sell | 2 k | 173,74 | 289 k USD |
| 2025-03-03 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 394 | 173,74 | 68 k USD |
| 2025-03-03 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 992 | 173,74 | 172 k USD |
| 2025-03-03 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 322 | 173,74 | 56 k USD |
| 2025-03-03 | Plewman Patrick | SVP for Diagnostic Services | Sell | 106 | 173,74 | 18 k USD |
| 2025-03-03 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 322 | 173,74 | 56 k USD |
| 2025-03-03 | Plewman Patrick | SVP for Diagnostic Services | Sell | 106 | 173,74 | 18 k USD |
| 2025-03-03 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 992 | 173,74 | 172 k USD |
| 2025-03-03 | Davis J. E. | CEO and President | Sell | 2 k | 173,74 | 289 k USD |
| 2025-03-03 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 394 | 173,74 | 68 k USD |
| 2025-03-03 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 173,74 | 294 k USD |
| 2025-02-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 824 | 172,61 | 142 k USD |
| 2025-02-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 528 | 172,61 | 91 k USD |
| 2025-02-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 824 | 172,61 | 142 k USD |
| 2025-02-27 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 528 | 172,61 | 91 k USD |
| 2025-02-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 214 | 171,75 | 37 k USD |
| 2025-02-26 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 88 | 171,75 | 15 k USD |
| 2025-02-26 | Davis J. E. | CEO and President | Sell | 3 k | 171,75 | 509 k USD |
| 2025-02-26 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 455 | 171,75 | 78 k USD |
| 2025-02-26 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 233 | 171,75 | 40 k USD |
| 2025-02-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 286 | 171,75 | 49 k USD |
| 2025-02-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 229 | 171,75 | 39 k USD |
| 2025-02-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 214 | 171,75 | 37 k USD |
| 2025-02-26 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 88 | 171,75 | 15 k USD |
| 2025-02-26 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 455 | 171,75 | 78 k USD |
| 2025-02-26 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 233 | 171,75 | 40 k USD |
| 2025-02-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 229 | 171,75 | 39 k USD |
| 2025-02-26 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 286 | 171,75 | 49 k USD |
| 2025-02-26 | Davis J. E. | CEO and President | Sell | 3 k | 171,75 | 509 k USD |
| 2025-02-26 | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | 171,75 | 149 k USD |
| 2025-02-26 | SAMAD SAM | Executive Vice President & CFO | Sell | 869 | 171,75 | 149 k USD |
| 2025-02-20 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 899 | 170,99 | 154 k USD |
| 2025-02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 604 | 170,99 | 103 k USD |
| 2025-02-20 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 899 | 170,99 | 154 k USD |
| 2025-02-20 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 604 | 170,99 | 103 k USD |
| 2025-02-19 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 242 | 169,71 | 41 k USD |
| 2025-02-19 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 99 | 169,71 | 17 k USD |
| 2025-02-19 | Davis J. E. | CEO and President | Sell | 3 k | 169,71 | 498 k USD |
| 2025-02-19 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 535 | 169,71 | 91 k USD |
| 2025-02-19 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 287 | 169,71 | 49 k USD |
| 2025-02-19 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 374 | 169,71 | 63 k USD |
| 2025-02-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 320 | 169,71 | 54 k USD |
| 2025-02-19 | Davis J. E. | CEO and President | Sell | 3 k | 169,71 | 498 k USD |
| 2025-02-19 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 242 | 169,71 | 41 k USD |
| 2025-02-19 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 99 | 169,71 | 17 k USD |
| 2025-02-19 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 535 | 169,71 | 91 k USD |
| 2025-02-19 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 287 | 169,71 | 49 k USD |
| 2025-02-19 | Plewman Patrick | SVP for Diagnostic Services | Sell | 320 | 169,71 | 54 k USD |
| 2025-02-19 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 374 | 169,71 | 63 k USD |
| 2025-02-19 | SAMAD SAM | Executive Vice President & CFO | Sell | 1 k | 169,71 | 175 k USD |
| 2025-02-19 | SAMAD SAM | Executive Vice President & CFO | Sell | 1 k | 169,71 | 175 k USD |
| 2025-02-12 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 454 | 0,00 | 0 USD |
| 2025-02-12 | Davis J. E. | CEO and President | Buy | 18 k | 0,00 | 0 USD |
| 2025-02-12 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 3 k | 0,00 | 0 USD |
| 2025-02-12 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 454 | 0,00 | 0 USD |
| 2025-02-12 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 3 k | 0,00 | 0 USD |
| 2025-02-12 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2025-02-12 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2025-02-12 | Davis J. E. | CEO and President | Buy | 18 k | 0,00 | 0 USD |
| 2025-02-12 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2025-02-05 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 403 | 164,30 | 66 k USD |
| 2025-02-05 | Gregg Vicky B | Director | Sell | 1 k | 164,57 | 206 k USD |
| 2025-02-05 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 403 | 164,30 | 66 k USD |
| 2025-02-05 | Gregg Vicky B | Director | Sell | 1 k | 164,57 | 206 k USD |
| 2025-01-29 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 4 | 158,03 | 632 USD |
| 2025-01-29 | Gregg Vicky B | Director | Buy | 72 | 158,04 | 11 k USD |
| 2025-01-29 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 12 | 158,03 | 2 k USD |
| 2025-01-29 | Plewman Patrick | SVP for Diagnostic Services | Buy | 57 | 158,04 | 9 k USD |
| 2025-01-29 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 4 | 158,03 | 632 USD |
| 2025-01-29 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 12 | 158,03 | 2 k USD |
| 2025-01-29 | Plewman Patrick | SVP for Diagnostic Services | Buy | 57 | 158,04 | 9 k USD |
| 2025-01-29 | SAMAD SAM | Executive Vice President & CFO | Buy | 35 | 158,04 | 6 k USD |
| 2025-01-29 | Gregg Vicky B | Director | Buy | 72 | 158,04 | 11 k USD |
| 2025-01-29 | SAMAD SAM | Executive Vice President & CFO | Buy | 35 | 158,04 | 6 k USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 35 k | 86,63 | 3.0 mn USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 162,26 | 488 k USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 32 k | 163,15 | 5.2 mn USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 35 k | 86,63 | 3.0 mn USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 162,26 | 488 k USD |
| 2024-11-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 32 k | 163,15 | 5.2 mn USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 33 k | 103,57 | 3.4 mn USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 162,14 | 779 k USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 28 k | 163,13 | 4.6 mn USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 33 k | 103,57 | 3.4 mn USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 5 k | 162,14 | 779 k USD |
| 2024-11-27 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 28 k | 163,13 | 4.6 mn USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 9 k | 71,17 | 615 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 10 k | 66,51 | 673 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 152,70 | 321 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 153,98 | 370 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 4 k | 154,74 | 640 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 3 k | 152,71 | 397 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 154,03 | 359 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 5 k | 154,74 | 803 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 9 k | 71,17 | 615 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 10 k | 66,51 | 673 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 152,70 | 321 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 153,98 | 370 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 4 k | 154,74 | 640 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 3 k | 152,71 | 397 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 2 k | 154,03 | 359 k USD |
| 2024-11-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 5 k | 154,74 | 803 k USD |
| 2024-10-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 156,92 | 279 k USD |
| 2024-10-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 156,92 | 279 k USD |
| 2024-10-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 4 | 149,39 | 598 USD |
| 2024-10-21 | Gregg Vicky B | Director | Buy | 76 | 149,37 | 11 k USD |
| 2024-10-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 21 | 149,37 | 3 k USD |
| 2024-10-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 60 | 149,37 | 9 k USD |
| 2024-10-21 | Plewman Patrick | SVP for Diagnostic Services | Buy | 60 | 149,37 | 9 k USD |
| 2024-10-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 21 | 149,37 | 3 k USD |
| 2024-10-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 37 | 149,37 | 6 k USD |
| 2024-10-21 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 4 | 149,39 | 598 USD |
| 2024-10-21 | Gregg Vicky B | Director | Buy | 76 | 149,37 | 11 k USD |
| 2024-10-21 | SAMAD SAM | Executive Vice President & CFO | Buy | 37 | 149,37 | 6 k USD |
| 2024-09-24 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 120 | 155,70 | 19 k USD |
| 2024-09-24 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 120 | 155,70 | 19 k USD |
| 2024-08-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 33 k | 95,80 | 3.1 mn USD |
| 2024-08-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 33 k | 154,97 | 5.0 mn USD |
| 2024-08-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 33 k | 95,80 | 3.1 mn USD |
| 2024-08-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 33 k | 154,97 | 5.0 mn USD |
| 2024-08-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 153,26 | 305 k USD |
| 2024-08-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 153,26 | 305 k USD |
| 2024-08-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | 149,46 | 11 k USD |
| 2024-08-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | 149,46 | 11 k USD |
| 2024-07-24 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 420 | 143,08 | 60 k USD |
| 2024-07-24 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 420 | 143,08 | 60 k USD |
| 2024-07-22 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 6 | 146,98 | 882 USD |
| 2024-07-22 | Gregg Vicky B | Director | Buy | 77 | 146,97 | 11 k USD |
| 2024-07-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 31 | 146,97 | 5 k USD |
| 2024-07-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 60 | 146,97 | 9 k USD |
| 2024-07-22 | Gregg Vicky B | Director | Buy | 77 | 146,97 | 11 k USD |
| 2024-07-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 60 | 146,97 | 9 k USD |
| 2024-07-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 31 | 146,97 | 5 k USD |
| 2024-07-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 21 | 146,97 | 3 k USD |
| 2024-07-22 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 6 | 146,98 | 882 USD |
| 2024-07-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 21 | 146,97 | 3 k USD |
| 2024-07-16 | SAMAD SAM | Executive Vice President & CFO | Sell | 4 k | 142,65 | 558 k USD |
| 2024-07-16 | SAMAD SAM | Executive Vice President & CFO | Sell | 4 k | 142,65 | 558 k USD |
| 2024-05-16 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | CARTER ROBERT B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-05-16 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2024-04-29 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 140,00 | 246 k USD |
| 2024-04-29 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 2 k | 140,00 | 246 k USD |
| 2024-04-22 | Gregg Vicky B | Director | Buy | 81 | 126,24 | 10 k USD |
| 2024-04-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 45 | 126,25 | 6 k USD |
| 2024-04-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 69 | 126,25 | 9 k USD |
| 2024-04-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 24 | 126,25 | 3 k USD |
| 2024-04-22 | Plewman Patrick | SVP for Diagnostic Services | Buy | 69 | 126,25 | 9 k USD |
| 2024-04-22 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 45 | 126,25 | 6 k USD |
| 2024-04-22 | Gregg Vicky B | Director | Buy | 81 | 126,24 | 10 k USD |
| 2024-04-22 | SAMAD SAM | Executive Vice President & CFO | Buy | 24 | 126,25 | 3 k USD |
| 2024-03-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | 128,11 | 22 k USD |
| 2024-03-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 114 | 128,11 | 15 k USD |
| 2024-03-26 | Plewman Patrick | SVP for Diagnostic Services | Sell | 114 | 128,11 | 15 k USD |
| 2024-03-26 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | 128,11 | 22 k USD |
| 2024-02-29 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1 k | 125,88 | 149 k USD |
| 2024-02-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 125,88 | 706 k USD |
| 2024-02-29 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 125,88 | 706 k USD |
| 2024-02-29 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 1 k | 125,88 | 149 k USD |
| 2024-02-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 225 | 126,36 | 28 k USD |
| 2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 52 | 126,36 | 7 k USD |
| 2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 57 | 126,36 | 7 k USD |
| 2024-02-28 | Davis J. E. | CEO and President | Sell | 3 k | 126,36 | 406 k USD |
| 2024-02-28 | Davis J. E. | CEO and President | Sell | 2 k | 126,36 | 228 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 644 | 126,36 | 81 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 557 | 126,36 | 70 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 126,57 | 703 k USD |
| 2024-02-28 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 262 | 126,36 | 33 k USD |
| 2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 205 | 126,36 | 26 k USD |
| 2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 68 | 126,36 | 9 k USD |
| 2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 405 | 126,36 | 51 k USD |
| 2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 456 | 126,36 | 58 k USD |
| 2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | Sell | 228 | 126,36 | 29 k USD |
| 2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | Sell | 105 | 126,36 | 13 k USD |
| 2024-02-28 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 225 | 126,36 | 28 k USD |
| 2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 52 | 126,36 | 7 k USD |
| 2024-02-28 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 57 | 126,36 | 7 k USD |
| 2024-02-28 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 262 | 126,36 | 33 k USD |
| 2024-02-28 | Davis J. E. | CEO and President | Sell | 3 k | 126,36 | 406 k USD |
| 2024-02-28 | Davis J. E. | CEO and President | Sell | 2 k | 126,36 | 228 k USD |
| 2024-02-28 | SAMAD SAM | Executive Vice President & CFO | Sell | 656 | 126,36 | 83 k USD |
| 2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 205 | 126,36 | 26 k USD |
| 2024-02-28 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 68 | 126,36 | 9 k USD |
| 2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 405 | 126,36 | 51 k USD |
| 2024-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 456 | 126,36 | 58 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 644 | 126,36 | 81 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 557 | 126,36 | 70 k USD |
| 2024-02-28 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 6 k | 126,57 | 703 k USD |
| 2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | Sell | 228 | 126,36 | 29 k USD |
| 2024-02-28 | Plewman Patrick | SVP for Diagnostic Services | Sell | 105 | 126,36 | 13 k USD |
| 2024-02-28 | SAMAD SAM | Executive Vice President & CFO | Sell | 656 | 126,36 | 83 k USD |
| 2024-02-23 | Davis J. E. | CEO and President | Buy | 13 k | 125,02 | 1.7 mn USD |
| 2024-02-23 | Davis J. E. | CEO and President | Sell | 7 k | 125,02 | 816 k USD |
| 2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 9 k | 125,02 | 1.2 mn USD |
| 2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 4 k | 125,02 | 470 k USD |
| 2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 125,02 | 255 k USD |
| 2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 619 | 125,02 | 77 k USD |
| 2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 8 k | 125,02 | 946 k USD |
| 2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 125,02 | 353 k USD |
| 2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 125,02 | 299 k USD |
| 2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | Sell | 869 | 125,02 | 109 k USD |
| 2024-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 2 k | 125,02 | 211 k USD |
| 2024-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 631 | 125,02 | 79 k USD |
| 2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 125,02 | 255 k USD |
| 2024-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 619 | 125,02 | 77 k USD |
| 2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | Buy | 9 k | 125,02 | 1.2 mn USD |
| 2024-02-23 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 4 k | 125,02 | 470 k USD |
| 2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 125,02 | 299 k USD |
| 2024-02-23 | Plewman Patrick | SVP for Diagnostic Services | Sell | 869 | 125,02 | 109 k USD |
| 2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 8 k | 125,02 | 946 k USD |
| 2024-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 3 k | 125,02 | 353 k USD |
| 2024-02-23 | Davis J. E. | CEO and President | Buy | 13 k | 125,02 | 1.7 mn USD |
| 2024-02-23 | Davis J. E. | CEO and President | Sell | 7 k | 125,02 | 816 k USD |
| 2024-02-23 | Gregg Vicky B | Director | Sell | 3 k | 126,64 | 317 k USD |
| 2024-02-23 | Gregg Vicky B | Director | Sell | 3 k | 126,64 | 317 k USD |
| 2024-02-22 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 821 | 126,14 | 104 k USD |
| 2024-02-22 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | 126,14 | 83 k USD |
| 2024-02-22 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 821 | 126,14 | 104 k USD |
| 2024-02-22 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | 126,14 | 83 k USD |
| 2024-02-21 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 89 | 125,02 | 11 k USD |
| 2024-02-21 | Davis J. E. | CEO and President | Sell | 762 | 125,02 | 95 k USD |
| 2024-02-21 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 493 | 125,02 | 62 k USD |
| 2024-02-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 102 | 125,02 | 13 k USD |
| 2024-02-21 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 407 | 125,02 | 51 k USD |
| 2024-02-21 | Plewman Patrick | SVP for Diagnostic Services | Sell | 139 | 125,02 | 17 k USD |
| 2024-02-21 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 89 | 125,02 | 11 k USD |
| 2024-02-21 | Doherty Catherine T. | EVP, Regional Businesses | Sell | 493 | 125,02 | 62 k USD |
| 2024-02-21 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 102 | 125,02 | 13 k USD |
| 2024-02-21 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 407 | 125,02 | 51 k USD |
| 2024-02-21 | Davis J. E. | CEO and President | Sell | 762 | 125,02 | 95 k USD |
| 2024-02-21 | Plewman Patrick | SVP for Diagnostic Services | Sell | 139 | 125,02 | 17 k USD |
| 2024-02-14 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 558 | 0,00 | 0 USD |
| 2024-02-14 | Davis J. E. | CEO and President | Buy | 22 k | 0,00 | 0 USD |
| 2024-02-14 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 4 k | 0,00 | 0 USD |
| 2024-02-14 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-14 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 558 | 0,00 | 0 USD |
| 2024-02-14 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 4 k | 0,00 | 0 USD |
| 2024-02-14 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-14 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2024-02-14 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 3 k | 0,00 | 0 USD |
| 2024-02-14 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Buy | 2 k | 0,00 | 0 USD |
| 2024-02-14 | Davis J. E. | CEO and President | Buy | 22 k | 0,00 | 0 USD |
| 2024-02-14 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2024-01-31 | Gregg Vicky B | Director | Buy | 88 | 129,33 | 11 k USD |
| 2024-01-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 29 | 129,33 | 4 k USD |
| 2024-01-31 | Plewman Patrick | SVP for Diagnostic Services | Buy | 50 | 129,33 | 6 k USD |
| 2024-01-31 | Plewman Patrick | SVP for Diagnostic Services | Buy | 50 | 129,33 | 6 k USD |
| 2024-01-31 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 29 | 129,33 | 4 k USD |
| 2024-01-31 | SAMAD SAM | Executive Vice President & CFO | Buy | 17 | 129,33 | 2 k USD |
| 2024-01-31 | Gregg Vicky B | Director | Buy | 88 | 129,33 | 11 k USD |
| 2024-01-31 | SAMAD SAM | Executive Vice President & CFO | Buy | 17 | 129,33 | 2 k USD |
| 2023-10-23 | Gregg Vicky B | Director | Buy | 92 | 122,86 | 11 k USD |
| 2023-10-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 30 | 122,86 | 4 k USD |
| 2023-10-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 52 | 122,84 | 6 k USD |
| 2023-10-23 | SAMAD SAM | Executive Vice President & CFO | Buy | 18 | 122,86 | 2 k USD |
| 2023-10-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 52 | 122,84 | 6 k USD |
| 2023-10-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 30 | 122,86 | 4 k USD |
| 2023-10-23 | Gregg Vicky B | Director | Buy | 92 | 122,86 | 11 k USD |
| 2023-10-23 | SAMAD SAM | Executive Vice President & CFO | Buy | 18 | 122,86 | 2 k USD |
| 2023-09-25 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 116 | 126,22 | 15 k USD |
| 2023-09-25 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Sell | 116 | 126,22 | 15 k USD |
| 2023-08-15 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | 135,23 | 10 k USD |
| 2023-08-15 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 74 | 135,23 | 10 k USD |
| 2023-07-25 | Gregg Vicky B | Director | Buy | 78 | 144,59 | 11 k USD |
| 2023-07-25 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 25 | 144,59 | 4 k USD |
| 2023-07-25 | Plewman Patrick | SVP for Diagnostic Services | Buy | 44 | 144,59 | 6 k USD |
| 2023-07-25 | Plewman Patrick | SVP for Diagnostic Services | Buy | 44 | 144,59 | 6 k USD |
| 2023-07-25 | Gregg Vicky B | Director | Buy | 78 | 144,59 | 11 k USD |
| 2023-07-25 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 25 | 144,59 | 4 k USD |
| 2023-07-14 | SAMAD SAM | Executive Vice President & CFO | Sell | 4 k | 140,18 | 548 k USD |
| 2023-07-14 | SAMAD SAM | Executive Vice President & CFO | Sell | 4 k | 140,18 | 548 k USD |
| 2023-05-17 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | WILENSKY GAIL R | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | Diaz Luis | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-05-17 | WILENSKY GAIL R | Director | Buy | 1 k | 0,00 | 0 USD |
| 2023-04-24 | Gregg Vicky B | Director | Buy | 72 | 143,08 | 10 k USD |
| 2023-04-24 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 25 | 143,08 | 4 k USD |
| 2023-04-24 | Plewman Patrick | SVP for Diagnostic Services | Buy | 44 | 143,08 | 6 k USD |
| 2023-04-24 | Gregg Vicky B | Director | Buy | 72 | 143,08 | 10 k USD |
| 2023-04-24 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 25 | 143,08 | 4 k USD |
| 2023-04-24 | Plewman Patrick | SVP for Diagnostic Services | Buy | 44 | 143,08 | 6 k USD |
| 2023-03-24 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | 134,25 | 23 k USD |
| 2023-03-24 | Plewman Patrick | SVP for Diagnostic Services | Sell | 99 | 134,25 | 13 k USD |
| 2023-03-24 | DELANEY MARK E | SVP & Chief Commercial Officer | Sell | 170 | 134,25 | 23 k USD |
| 2023-03-24 | Plewman Patrick | SVP for Diagnostic Services | Sell | 99 | 134,25 | 13 k USD |
| 2023-03-07 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 5 k | 140,55 | 746 k USD |
| 2023-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 140,55 | 668 k USD |
| 2023-03-07 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 5 k | 140,55 | 746 k USD |
| 2023-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 140,55 | 668 k USD |
| 2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 2 k | 147,86 | 284 k USD |
| 2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 682 | 147,86 | 101 k USD |
| 2023-03-06 | Davis J. E. | CEO and President | Buy | 15 k | 147,86 | 2.2 mn USD |
| 2023-03-06 | Davis J. E. | CEO and President | Sell | 8 k | 147,86 | 1.2 mn USD |
| 2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 10 k | 147,86 | 1.5 mn USD |
| 2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 5 k | 147,86 | 682 k USD |
| 2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 147,86 | 294 k USD |
| 2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 583 | 147,86 | 86 k USD |
| 2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 9 k | 147,86 | 1.3 mn USD |
| 2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 147,86 | 568 k USD |
| 2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | Buy | 3 k | 147,86 | 381 k USD |
| 2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 799 | 147,86 | 118 k USD |
| 2023-03-06 | RUSCKOWSKI STEPHEN H | Director | Buy | 83 k | 147,86 | 12.2 mn USD |
| 2023-03-06 | RUSCKOWSKI STEPHEN H | Director | Sell | 39 k | 147,86 | 5.7 mn USD |
| 2023-03-06 | Davis J. E. | CEO and President | Buy | 15 k | 147,86 | 2.2 mn USD |
| 2023-03-06 | Davis J. E. | CEO and President | Sell | 8 k | 147,86 | 1.2 mn USD |
| 2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 147,86 | 294 k USD |
| 2023-03-06 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 583 | 147,86 | 86 k USD |
| 2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 2 k | 147,86 | 284 k USD |
| 2023-03-06 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 682 | 147,86 | 101 k USD |
| 2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | Buy | 3 k | 147,86 | 381 k USD |
| 2023-03-06 | Plewman Patrick | SVP for Diagnostic Services | Sell | 799 | 147,86 | 118 k USD |
| 2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 10 k | 147,86 | 1.5 mn USD |
| 2023-03-06 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 5 k | 147,86 | 682 k USD |
| 2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 9 k | 147,86 | 1.3 mn USD |
| 2023-03-06 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 4 k | 147,86 | 568 k USD |
| 2023-03-06 | RUSCKOWSKI STEPHEN H | Director | Buy | 83 k | 147,86 | 12.2 mn USD |
| 2023-03-06 | RUSCKOWSKI STEPHEN H | Director | Sell | 39 k | 147,86 | 5.7 mn USD |
| 2023-03-03 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 717 | 140,63 | 101 k USD |
| 2023-03-03 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 717 | 140,63 | 101 k USD |
| 2023-03-02 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 593 | 138,54 | 82 k USD |
| 2023-03-02 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 593 | 138,54 | 82 k USD |
| 2023-03-01 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 68 | 140,69 | 10 k USD |
| 2023-03-01 | Davis J. E. | CEO and President | Sell | 1 k | 140,69 | 182 k USD |
| 2023-03-01 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 392 | 140,69 | 55 k USD |
| 2023-03-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 65 | 140,69 | 9 k USD |
| 2023-03-01 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 320 | 140,69 | 45 k USD |
| 2023-03-01 | Plewman Patrick | SVP for Diagnostic Services | Sell | 90 | 140,69 | 13 k USD |
| 2023-03-01 | Davis J. E. | CEO and President | Sell | 1 k | 140,69 | 182 k USD |
| 2023-03-01 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 392 | 140,69 | 55 k USD |
| 2023-03-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 65 | 140,69 | 9 k USD |
| 2023-03-01 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 68 | 140,69 | 10 k USD |
| 2023-03-01 | Plewman Patrick | SVP for Diagnostic Services | Sell | 90 | 140,69 | 13 k USD |
| 2023-03-01 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 320 | 140,69 | 45 k USD |
| 2023-03-01 | RUSCKOWSKI STEPHEN H | Director | Sell | 3 k | 140,69 | 492 k USD |
| 2023-03-01 | RUSCKOWSKI STEPHEN H | Director | Sell | 3 k | 140,69 | 492 k USD |
| 2023-02-24 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 2 k | 141,42 | 239 k USD |
| 2023-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 141,42 | 200 k USD |
| 2023-02-24 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 2 k | 141,42 | 239 k USD |
| 2023-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 1 k | 141,42 | 200 k USD |
| 2023-02-23 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 188 | 147,86 | 28 k USD |
| 2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 498 | 0,00 | 0 USD |
| 2023-02-23 | Davis J. E. | CEO and President | Sell | 1 k | 147,86 | 218 k USD |
| 2023-02-23 | Davis J. E. | CEO and President | Buy | 17 k | 0,00 | 0 USD |
| 2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 962 | 147,86 | 142 k USD |
| 2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 4 k | 0,00 | 0 USD |
| 2023-02-23 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 195 | 147,86 | 29 k USD |
| 2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 811 | 147,86 | 120 k USD |
| 2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | Sell | 245 | 147,86 | 36 k USD |
| 2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | DELANEY MARK E | SVP & Chief Commercial Officer | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 962 | 147,86 | 142 k USD |
| 2023-02-23 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 4 k | 0,00 | 0 USD |
| 2023-02-23 | GARDNER MARK A | SVP of Molecular Gen & Oncol | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Sell | 195 | 147,86 | 29 k USD |
| 2023-02-23 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Sell | 188 | 147,86 | 28 k USD |
| 2023-02-23 | DEPPE MICHAEL J | SVP, Corp. Controller & CAO | Buy | 498 | 0,00 | 0 USD |
| 2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | Sell | 245 | 147,86 | 36 k USD |
| 2023-02-23 | Plewman Patrick | SVP for Diagnostic Services | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 811 | 147,86 | 120 k USD |
| 2023-02-23 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 2 k | 0,00 | 0 USD |
| 2023-02-23 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2023-02-23 | RUSCKOWSKI STEPHEN H | Director | Sell | 6 k | 147,86 | 861 k USD |
| 2023-02-23 | RUSCKOWSKI STEPHEN H | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-02-23 | Davis J. E. | CEO and President | Sell | 1 k | 147,86 | 218 k USD |
| 2023-02-23 | Davis J. E. | CEO and President | Buy | 17 k | 0,00 | 0 USD |
| 2023-02-23 | RUSCKOWSKI STEPHEN H | Director | Sell | 6 k | 147,86 | 861 k USD |
| 2023-02-23 | RUSCKOWSKI STEPHEN H | Director | Buy | 20 k | 0,00 | 0 USD |
| 2023-02-23 | SAMAD SAM | Executive Vice President & CFO | Buy | 5 k | 0,00 | 0 USD |
| 2023-02-01 | Gregg Vicky B | Director | Buy | 64 | 146,75 | 9 k USD |
| 2023-02-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 13 | 146,75 | 2 k USD |
| 2023-02-01 | Plewman Patrick | SVP for Diagnostic Services | Buy | 27 | 146,75 | 4 k USD |
| 2023-02-01 | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Buy | 13 | 146,75 | 2 k USD |
| 2023-02-01 | Plewman Patrick | SVP for Diagnostic Services | Buy | 27 | 146,75 | 4 k USD |
| 2023-02-01 | Gregg Vicky B | Director | Buy | 64 | 146,75 | 9 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Buy | 972 | 62,01 | 60 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Buy | 1 k | 53,13 | 56 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Sell | 2 k | 152,50 | 309 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Buy | 972 | 62,01 | 60 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Buy | 1 k | 53,13 | 56 k USD |
| 2022-12-01 | RING TIMOTHY M | Director | Sell | 2 k | 152,50 | 309 k USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 41 k | 86,63 | 3.5 mn USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 17 k | 148,92 | 2.6 mn USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 23 k | 149,37 | 3.5 mn USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Buy | 41 k | 86,63 | 3.5 mn USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 17 k | 148,92 | 2.6 mn USD |
| 2022-11-28 | Doherty Catherine T. | SVP, Regional Businesses | Sell | 23 k | 149,37 | 3.5 mn USD |
| 2022-11-01 | Davis J. E. | CEO and President | Buy | 14 k | 0,00 | 0 USD |
| 2022-11-01 | Davis J. E. | CEO and President | Buy | 14 k | 0,00 | 0 USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 260 | 61,23 | 16 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 1 k | 60,79 | 83 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 369 | 62,01 | 23 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Sell | 2 k | 144,06 | 288 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 260 | 61,23 | 16 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 1 k | 60,79 | 83 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Buy | 369 | 62,01 | 23 k USD |
| 2022-11-01 | RING TIMOTHY M | Director | Sell | 2 k | 144,06 | 288 k USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 9 k | 52,17 | 476 k USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 6 k | 56,12 | 358 k USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 15 k | 145,00 | 2.2 mn USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 9 k | 52,17 | 476 k USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 6 k | 56,12 | 358 k USD |
| 2022-10-26 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 15 k | 145,00 | 2.2 mn USD |
| 2022-10-19 | Gregg Vicky B | Director | Buy | 74 | 127,67 | 9 k USD |
| 2022-10-19 | Gregg Vicky B | Director | Buy | 74 | 127,67 | 9 k USD |
| 2022-10-03 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 122 k USD |
| 2022-10-03 | RING TIMOTHY M | Director | Sell | 2 k | 123,39 | 247 k USD |
| 2022-10-03 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 122 k USD |
| 2022-10-03 | RING TIMOTHY M | Director | Sell | 2 k | 123,39 | 247 k USD |
| 2022-09-01 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 122 k USD |
| 2022-09-01 | RING TIMOTHY M | Director | Sell | 2 k | 125,02 | 250 k USD |
| 2022-09-01 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 122 k USD |
| 2022-09-01 | RING TIMOTHY M | Director | Sell | 2 k | 125,02 | 250 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Buy | 149 | 56,25 | 8 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 113 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Sell | 2 k | 136,04 | 272 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Buy | 149 | 56,25 | 8 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Buy | 2 k | 61,23 | 113 k USD |
| 2022-08-01 | RING TIMOTHY M | Director | Sell | 2 k | 136,04 | 272 k USD |
| 2022-07-20 | Gregg Vicky B | Director | Buy | 70 | 134,47 | 9 k USD |
| 2022-07-20 | Gregg Vicky B | Director | Buy | 70 | 134,47 | 9 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Buy | 1 k | 56,25 | 57 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Buy | 990 | 58,69 | 58 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Sell | 2 k | 133,47 | 267 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Buy | 1 k | 56,25 | 57 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Buy | 990 | 58,69 | 58 k USD |
| 2022-07-01 | RING TIMOTHY M | Director | Sell | 2 k | 133,47 | 267 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 10 k | 103,57 | 1.0 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 7 k | 140,60 | 959 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 3 k | 141,36 | 363 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 651 | 142,15 | 93 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 15 k | 86,63 | 1.3 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 10 k | 140,58 | 1.4 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 4 k | 141,35 | 584 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 900 | 142,13 | 128 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 10 k | 103,57 | 1.0 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 7 k | 140,60 | 959 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 3 k | 141,36 | 363 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 651 | 142,15 | 93 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 15 k | 86,63 | 1.3 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 10 k | 140,58 | 1.4 mn USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 4 k | 141,35 | 584 k USD |
| 2022-05-25 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 900 | 142,13 | 128 k USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 126 k | 103,57 | 13.1 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 126 k | 140,12 | 17.7 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 156 k | 86,63 | 13.5 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 156 k | 140,12 | 21.9 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 126 k | 103,57 | 13.1 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 126 k | 140,12 | 17.7 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 156 k | 86,63 | 13.5 mn USD |
| 2022-05-24 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 156 k | 140,12 | 21.9 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 35 k | 103,57 | 3.6 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 34 k | 140,12 | 4.7 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 800 | 141,54 | 113 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 200 | 142,26 | 28 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 43 k | 86,63 | 3.7 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 41 k | 140,12 | 5.8 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 1 k | 141,51 | 142 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 300 | 142,24 | 43 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 35 k | 103,57 | 3.6 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 34 k | 140,12 | 4.7 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 800 | 141,54 | 113 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 200 | 142,26 | 28 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 43 k | 86,63 | 3.7 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 41 k | 140,12 | 5.8 mn USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 1 k | 141,51 | 142 k USD |
| 2022-05-23 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 300 | 142,24 | 43 k USD |
| 2022-05-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 8 | 136,98 | 1 k USD |
| 2022-05-18 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | Lassiter Wright III | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | MORRISON DENISE M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | Gregg Vicky B | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | MAIN TIMOTHY L | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | PFEIFFER GARY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | Doi Tracey | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | WILENSKY GAIL R | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 8 | 136,98 | 1 k USD |
| 2022-05-18 | RING TIMOTHY M | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-18 | WILENSKY GAIL R | Director | Buy | 1 k | 0,00 | 0 USD |
| 2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 51 k | 66,51 | 3.4 mn USD |
| 2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 51 k | 139,97 | 7.1 mn USD |
| 2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 51 k | 66,51 | 3.4 mn USD |
| 2022-05-17 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 51 k | 139,97 | 7.1 mn USD |
| 2022-04-18 | Gregg Vicky B | Director | Buy | 61 | 134,88 | 8 k USD |
| 2022-04-18 | Gregg Vicky B | Director | Buy | 61 | 134,88 | 8 k USD |
| 2022-03-08 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 7 k | 135,21 | 951 k USD |
| 2022-03-08 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 135,21 | 842 k USD |
| 2022-03-08 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 7 k | 135,21 | 951 k USD |
| 2022-03-08 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 6 k | 135,21 | 842 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 2 k | 130,09 | 301 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 835 | 130,09 | 109 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 206 | 130,09 | 27 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 79 | 130,09 | 10 k USD |
| 2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Buy | 20 k | 130,09 | 2.6 mn USD |
| 2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 10 k | 130,09 | 1.3 mn USD |
| 2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Buy | 13 k | 130,09 | 1.7 mn USD |
| 2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 6 k | 130,09 | 827 k USD |
| 2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Buy | 16 k | 130,09 | 2.1 mn USD |
| 2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 8 k | 130,09 | 1.0 mn USD |
| 2022-03-07 | GUINAN MARK | Executive Vice President & CFO | Buy | 21 k | 130,09 | 2.7 mn USD |
| 2022-03-07 | GUINAN MARK | Executive Vice President & CFO | Sell | 10 k | 130,09 | 1.4 mn USD |
| 2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 12 k | 130,09 | 1.5 mn USD |
| 2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 130,09 | 692 k USD |
| 2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Buy | 20 k | 130,09 | 2.6 mn USD |
| 2022-03-07 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Sell | 10 k | 130,09 | 1.3 mn USD |
| 2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Buy | 13 k | 130,09 | 1.7 mn USD |
| 2022-03-07 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 6 k | 130,09 | 827 k USD |
| 2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Buy | 16 k | 130,09 | 2.1 mn USD |
| 2022-03-07 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Sell | 8 k | 130,09 | 1.0 mn USD |
| 2022-03-07 | GUINAN MARK | Executive Vice President & CFO | Buy | 21 k | 130,09 | 2.7 mn USD |
| 2022-03-07 | GUINAN MARK | Executive Vice President & CFO | Sell | 10 k | 130,09 | 1.4 mn USD |
| 2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 12 k | 130,09 | 1.5 mn USD |
| 2022-03-07 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 5 k | 130,09 | 692 k USD |
| 2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 70 k | 130,09 | 9.1 mn USD |
| 2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 33 k | 130,09 | 4.2 mn USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 2 k | 130,09 | 301 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 835 | 130,09 | 109 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 206 | 130,09 | 27 k USD |
| 2022-03-07 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Sell | 79 | 130,09 | 10 k USD |
| 2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Buy | 70 k | 130,09 | 9.1 mn USD |
| 2022-03-07 | RUSCKOWSKI STEPHEN H | Chairman, CEO and President | Sell | 33 k | 130,09 | 4.2 mn USD |
| 2022-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | 130,00 | 86 k USD |
| 2022-02-28 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 661 | 130,00 | 86 k USD |
| 2022-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 549 | 0,00 | 0 USD |
| 2022-02-24 | DEPPE MICHAEL J | VP, Corp. Controller & CAO | Buy | 3 k | 0,00 | 0 USD |
| 2022-02-24 | Davis J. E. | EVP-Gen. Diagnostics/CEO Elect | Buy | 10 k | 0,00 | 0 USD |
| 2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Sell | 3 k | 126,26 | 347 k USD |
| 2022-02-24 | Doherty Catherine T. | SVP, Group Exec. Clin. Fran. | Buy | 3 k | 0,00 | 0 USD |
| 2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Buy | 4 k | 0,00 | 0 USD |
| 2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Buy | 8 k | 0,00 | 0 USD |
| 2022-02-24 | GUINAN MARK | Executive Vice President & CFO | Buy | 2 k | 0,00 | 0 USD |
| 2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Sell | 2 k | 126,26 | 211 k USD |
| 2022-02-24 | PREVOZNIK MICHAEL E | SVP & General Counsel | Buy | 3 k | 0,00 | 0 USD |
| 2022-02-24 | EGLINTON MANNER CARRIE | SVP, Advanced Diagnostics | Buy | 4 k | 0,00 | 0 USD |